Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hers vs Sesame Care

Hers
Site position #359

Lower grade

Sesame Care
Site position #2

Higher grade

The verdict

Sesame Care takes it — 87.8/100 to 60.7/100.

Sesame Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSesame Care +30
54
84
Dose & formulationSesame Care +15
77
92
Clinical oversightSesame Care +39
55
94
Labs & monitoringSesame Care +32
52
84
FulfillmentHers +1
81
80
Contract termsSesame Care +51
41
92
Hers · top barSesame Care · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricHersSesame Care
WeighScore60.7/10087.8/100
GradeCB+
Site position#359#2
SemaglutideFrom $149/mo (Wegovy pill; plus required care: $39 first month, then $149/mo)Brand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg — plus Sesame care: $59/mo only on the 12-month prepay, otherwise $99 billed every 28 days (13 charges a year)
TirzepatideFrom $299/mo (Zepbound vial or KwikPen; plus required care: $39 first month, then $149/mo)Brand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg) — plus Sesame care: $59/mo on the 12-month prepay, otherwise $99 per 28 days
CoverageNot available in every state; confirm eligibilityNationwide marketplace
Brand-name accessYesYes
Oral / sublingualYesYes
Hers

Site position #359 · C

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.

Strengths

  • Branded Wegovy pill and pen, plus Zepbound vial or KwikPen options listed
  • Ongoing provider messaging and monthly care-team follow-ups described
  • Published membership and medication charges can be compared separately

What to consider

  • Required care membership is $39 first month, then $149 monthly, extra to medication
  • Membership and medication cancellation are separate; shipped prepaid supply may keep membership charges payable
  • Availability and medication prices depend on state, product, dose and plan
  • FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025 concerning compounded-semaglutide promotion; this is distinct from current branded-product approval
Sesame Care

Site position #2 · B+

Strengths

  • Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
  • Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
  • You choose the provider and see the price up front — genuine marketplace transparency
  • Oral routes available (Wegovy pill, Rybelsus)

What to consider

  • A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
  • Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
  • Brand-name cash prices can run high without insurance

Featured provider

Sesame Care

Sesame Care scores 87.8/100 (B+). An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard